IBDS ETF Analysis: iBonds Dec 2027 Term | NYSE

Target Maturity Bonds | NYSE, USA | Market Cap: 3.998m USD | 12M Return: 3.6% | US46435UAA97 | Charts, Fundamentals & Technical Analysis

Corporate Bonds, Investment-Grade Bonds, 2027 Maturity Bonds, USD-Denominated Debt
Total Rating 52
Safety 66
Buy Signal -0.22
Target Maturity Bonds
Category Rotation: -7.7
TER: 0.09%
AUM: 4.00B
Avg Turnover: 16.4M
Risk 3d forecast
Volatility0.94%
VaR 5th Pctl0.15%
VaR vs Median-11.0%
Reward TTM
Sharpe Ratio-0.54
Rel. Str. IBD45.3
Rel. Str. Peer Group82.7 pctl
Character TTM
Beta0.025
Beta Downside-0.005
Hurst Exponent0.536
Choppyness1.19%
Drawdowns 3y
Max DD1.30%
CAGR/Max DD4.51
CAGR/Mean DD30.93

Warnings

Fakeout

Tailwinds

No distinct edge detected

Seasonality 9 years of data

Jan +0.1% 0
Feb -0.4% 31
Mar -0.3% 14
Apr +0.0% 14
May +0.6% 13
Jun +0.1% 12
Jul +0.5% 17
Aug +0.1% 17
Sep -0.7% 53
Oct -0.7% 52
Nov +0.0% 0
Dec +0.3% 28

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: IBDS iBonds Dec 2027 Term

The iShares iBonds Dec 2027 Term Corporate ETF (IBDS) is a target-maturity exchange-traded fund that tracks an index of U.S. dollar-denominated, investment-grade corporate bonds scheduled to mature in 2027. The fund commits at least 80% of its assets to the component securities of the underlying index and at least 90% to fixed income securities of the types represented in that index. As a target-maturity product, IBDS is structured to wind down or transition its holdings as the underlying bonds approach their 2027 maturity date, offering investors a defined investment horizon rather than a perpetual maturity profile.

Headlines to Watch Out For
  • Fed rate cut expectations lift investment-grade bond prices
  • Corporate credit spreads tighten as 2027 maturity approaches
  • Yield curve shifts drive total return toward par
What is the price of IBDS shares?

As of November 03, 2026, the stock is trading at USD 24.07 with a total of 509,295 shares traded. Over the past week, the price has changed by +0.11%, over one month by +0.44%, over three months by +0.77% and over the past year by +3.61%.

Current recommended Stop Loss: 24.00 (which is 0.3% or 1.8 ATR below the current price).

Is IBDS a buy, sell or hold?

iBonds Dec 2027 Term has no consensus analysts rating.